Clinical Trials Browser

Unknown × regorafenib × Dermatologic × Clear all

NCT05370807 2023-10-24

RegoMel

Phase 2 Unknown

Melanoma

NCT02501551 2021-04-05

Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy

Phase 2 Unknown

Melanoma